X-6

N/A

Report date: 2025/01/26 15:44:43
NME

Base Information

Drug NameX-6
Drug Alias NamecGMP-AMP Synthase Inhibitor (University of Washington/Southern Medical University)X-6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclic GMP-AMP synthase inhibitors
TargetsCyclic GMP-AMP synthase
Therapy Area/IndicationsLupus Erythematosus, SystemicBrain DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of Washington
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of WashingtonSouthern Hospital Of Southern Medical University
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicBrain DiseasesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A